These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2743835)

  • 1. Suppression of tumorigenicity by polar compounds that induce terminal differentiation of transformed cells.
    Ciba Found Symp; 1989; 142():71-8. PubMed ID: 2743835
    [No Abstract]   [Full Text] [Related]  

  • 2. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to neoplastic transformation induced by nonterminal differentiation.
    Estervig DN; Maercklein PB; Scott RE
    Cancer Res; 1989 Feb; 49(4):1008-13. PubMed ID: 2912546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human mucoepidermoid carcinoma MEC-1 cells induced differentiation by HMBA].
    Chen Y; SiTu Z; Wu J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Jan; 31(1):28-30. PubMed ID: 9275610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone.
    Blumenthal M; Kardosh A; Dubeau L; Borok Z; Schönthal AH
    Mol Carcinog; 2003 Dec; 38(4):160-9. PubMed ID: 14639655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells.
    Castle VP; Dixit VM; Polverini PJ
    Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
    Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
    J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation effect of hexamethylene bisacetamide (HMBA) on mucoepidermoid carcinoma in vivo].
    Jia B; Situ Z; Wu J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Mar; 31(2):85-7. PubMed ID: 9387538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the molecular weight and potency of polar compounds which induce the differentiation of HL-60 human promyelocytic leukemia cells.
    Langdon SP; Hickman JA
    Cancer Res; 1987 Jan; 47(1):140-4. PubMed ID: 3466688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carotenoids on in vitro proliferation and differentiation of oval cells during neoplastic and non-neoplastic liver injuries in rats.
    Wójcik M; Bobowiec R; Martelli F
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():203-13. PubMed ID: 18812639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The differentiation-inducing effect of tanshinone and retinoic acid on human cervical carcinoma cell line in vitro].
    Yuan S; Huang G; Wang X
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):422-4. PubMed ID: 8697992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation-induced ML-1 cells as targets for transformation by a chemical carcinogen.
    Guan XP; Bloch A
    Cancer Res; 1988 Aug; 48(15):4389-94. PubMed ID: 3164646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of cell differentiation on the induction and inhibition of cancers].
    Li SE
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):157-63, concl. PubMed ID: 7987945
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro modulation of oncogenesis and differentiation by retinoids and tumor promoters.
    Borek C; Miller RC; Geard CR; Guernsey DL; Smith JE
    Carcinog Compr Surv; 1982; 7():277-84. PubMed ID: 6461410
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme.
    Kashani-Sabet M; Funato T; Florenes VA; Fodstad O; Scanlon KJ
    Cancer Res; 1994 Feb; 54(4):900-2. PubMed ID: 8313379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
    Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
    Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line.
    Wier ML; Scott RE
    Cancer Res; 1985 Jul; 45(7):3339-46. PubMed ID: 4005857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
    Yam JW; Chan KW; Hsiao WL
    Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.